Human Osteoprotegerin ELISA Kit
Be the first to review this product! Submit a review
|
(21 Publications)
Human Osteoprotegerin ELISA Kit is a sandwich ELISA designed to quantify Human Osteoprotegerin with a sensitivity of 1 pg/mL.
- Colorimetric sandwich ELISA - 450 nm readout - works on any plate reader
- Wide dynamic range - quantifies 1.23 - 900 pg/mL
- Cited in over 10 publications
View Alternative Names
OCIF, OPG, TNFRSF11B, Tumor necrosis factor receptor superfamily member 11B, Osteoclastogenesis inhibitory factor, Osteoprotegerin
- sELISA
Supplier Data
Sandwich ELISA - Human Osteoprotegerin ELISA Kit (AB100617)
Representative Standard Curve using ab100617.
- sELISA
Supplier Data
Sandwich ELISA - Human Osteoprotegerin ELISA Kit (AB100617)
Representative Standard Curve using ab100617.
- sELISA
Lab
Sandwich ELISA - Human Osteoprotegerin ELISA Kit (AB100617)
- sELISA
Lab
Sandwich ELISA - Human Osteoprotegerin ELISA Kit (AB100617)
Osteoprotegerin measured in cell lysates showing quantity (pg) per mg of tested sample
Reactivity data
Product details
Human Osteoprotegerin ELISA Kit ab100617 is a sandwich ELISA to measure Human Osteoprotegerin in serum, plasma, cell culture supernatant, cell lysate with a sensitivity of 1 pg/ml.
How the assay works
This assay employs an antibody specific for Human Osteoprotegerin coated on a 96-well plate. Standards and samples are pipetted into the wells and Osteoprotegerin present in a sample is bound to the wells by the immobilized antibody. The wells are washed and biotinylated anti-Human Osteoprotegerin antibody is added. After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is pipetted to the wells. The wells are again washed, a TMB substrate solution is added to the wells and color develops in proportion to the amount of Osteoprotegerin bound. The Stop Solution changes the color from blue to yellow, and the intensity of the color is measured at 450 nm.
Produced using a non-baculovirus expression system.
Assay Specificity
Our ELISA kits are rigorously validated to ensure the highest level of consistency and reproducibility. Please check the protocol booklet for more details
Human Osteoprotegerin ELISA Kit ab100617 protocol summary
1. Add standard or sample to each well used. Incubate at room temperature
2. Wash and add prepared biotinylated antibody to each well. Incubate at room temperature.
3. Wash and add prepared streptavidin solution. Incubate at room temperature.
4. Add TMB Development Solution to each well. Incubate at room temperature.
5. Add Stop Solution to each well. Read at 450nm immediately.
Get results in 90 minutes with our SimpleStep ELISA® kit
Human Osteoprotegerin ELISA Kit (ab189580)
Optimization may be required with urine samples.
We recommend preparing serum-free or low-serum medium samples, as serum tends to contain cytokines which may produce significant background signals. If it is necessary to test serum-containing medium, we recommend also running an uncultured media blank to assess baseline signals. This baseline can then be subtracted from the cultured media sample data.
Recovery
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
OPG inhibits the differentiation and activation of osteoclasts by binding to RANKL preventing its interaction with the receptor RANK on the surface of osteoclast progenitor cells. As part of a non-classical signaling pathway OPG plays a significant role in the regulation of bone remodeling and maintenance by controlling bone resorption. This activity preserves bone density and structure by limiting excessive osteoclastic activity.
Pathways
OPG operates within the RANK/RANKL/OPG signaling axis which is important for bone metabolism. It counteracts the bone-resorption pathway driven by the RANKL-RANK interaction inhibiting osteoclastogenesis. This axis involves interactions with other proteins such as RANK RANKL and TRAIL where TRAIL's involvement hints towards a broader immune regulation role for OPG.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (21)
Recent publications for all applications. Explore the full list and refine your search
Molecular therapy : the journal of the American Society of Gene Therapy 32:3932-3954 PubMed39244641
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in endocrinology 15:1359052 PubMed39157681
2024
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 9: PubMed38780544
2024
Applications
Unspecified application
Species
Unspecified reactive species
BMC oral health 24:52 PubMed38191383
2024
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 181:429-446 PubMed37625900
2023
Applications
Unspecified application
Species
Unspecified reactive species
Materials (Basel, Switzerland) 15: PubMed35955174
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Korean journal of internal medicine 37:821-829 PubMed35468703
2022
Applications
Unspecified application
Species
Unspecified reactive species
Polymers 13: PubMed34641117
2021
Applications
Unspecified application
Species
Unspecified reactive species
Acta biomaterialia 135:689-704 PubMed34520883
2021
Applications
Unspecified application
Species
Unspecified reactive species
Diagnostics (Basel, Switzerland) 11: PubMed34206615
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com